Botanix Pharmaceuticals Limited
ASX:BOT.AX
Overview | Financials
Company Name | Botanix Pharmaceuticals Limited |
Symbol | BOT.AX |
Currency | AUD |
Price | 0.35 |
Market Cap | 636,111,000 |
Dividend Yield | 0% |
52-week-range | 0.12 - 0.445 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Vincent P. Ippolito |
Website | https://www.botanixpharma.com |
An error occurred while fetching data.
About Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD